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Abstract: Dental caries remains the most prevalent and costly oral infectious disease 
worldwide. Several methods have been employed to prevent this biofilm-dependent 
disease, including the use of essential oils (EOs). In this systematic review, we discuss the 
antibacterial activity of EOs and their isolated constituents in view of a potential 
applicability in novel dental formulations. Seven databases were systematically searched 
for clinical trials, in situ, in vivo and in vitro studies addressing the topic published up to 
date. Most of the knowledge in the literature is based on in vitro studies assessing the 
effects of EOs on caries-related streptococci (mainly Streptococcus mutans) and 
lactobacilli, and on a limited number of clinical trials. The most promising species with 
antibacterial potential against cariogenic bacteria are: Achillea ligustica, Baccharis 
dracunculifolia, Croton cajucara, Cryptomeria japonica, Coriandrum sativum, Eugenia 
caryophyllata, Lippia sidoides, Ocimum americanum, and Rosmarinus officinalis. In some 
cases, the major phytochemical compounds determine the biological properties of EOs. 
Menthol and eugenol were considered outstanding compounds demonstrating an 
antibacterial potential. Only L. sidoides mouthwash (1%) has shown clinical antimicrobial 
effects against oral pathogens thus far. This review suggests avenues for further non-clinical 
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and clinical studies with the most promising EOs and their isolated constituents 
bioprospected worldwide. 
Keywords: natural products; essential oils; monoterpenes; dental caries; Streptococcus 
mutans; preventive dentistry; clinical trials; isolated compounds 
 
1. Introduction 
Despite the advances in public policies so far, dental caries remains the most prevalent and costly  
oral infectious disease worldwide [1,2], representing a global public health problem to be managed by 
authorities and dental professionals [2,3]. Effective caries-preventive methods have been developed 
and amended in the last decades. It is well known that the chemical control of plaque is an effective 
strategy to prevent dental caries development [4]. The main chemical agents currently available are 
fluoride [5], chlorhexidine [6], triclosan, cetylpyridinium chloride and natural products [4,7]. 
In this context, natural products (plant extracts, essential oils and isolated compounds, and marine 
products) have been proposed as novel therapeutic agents against dental caries [8], in order to 
minimize the adverse effects of synthetics [9] (e.g., altered taste, mucosal desquamation and tooth 
staining) as well as to provide effective and safer alternatives for dental caries management. Examples 
of these natural products include propolis, black and green tea, cacao bean husk, oat hulls, cranberry, 
and shells of crustaceans, among several others [8]. 
Essential oils (EOs) have aroused attention among the naturally-occurring bioactive agents with 
promising antimicrobial activity [10,11]. EOs are a mixture of volatile constituents produced by 
aromatic plants as secondary metabolites, as a protective mechanism against predators, microorganisms 
or weather adversities [12,13]. Among the 100,000 known secondary metabolites, EOs account for 
over 3000, of which about 300 have commercial interest and are used by the food, cosmetic and 
pharmaceutical industries [10]. The diverse chemical structures of EOs encompass two groups with 
distinct biosynthetic origins [14]: terpenes (monoterpenes and sesquiterpenes) and terpenoids 
(isoprenoids), and another group of aliphatic and aromatic compounds (e.g., aldehydes, phenols, 
among others), all characterized by low molecular weight [12]. Monoterpenes are the major 
compounds found in EOs [12] and have been found to show potent antibacterial activity against  
caries-related microorganisms [11,15]. 
Despite the research progress so far, there have been few studies with EOs approaching their 
potential application in the field of dentistry. Usually, a few substances from this phytochemical class 
have been used in anti-plaque and anti-gingivitis mouthwash formulations [16–18], hence there is a 
need for further exploration of EOs with potential use as adjunctive anti-caries chemotherapy. 
In this systematic review, we discuss the anti-caries activity of EOs in view of their potential 
applicability in novel dental formulations. Moreover, the compilation of a vast database from the 
literature may suggest avenues for further laboratorial and clinical studies with the most promising EOs 
and their isolated constituents bioprospected worldwide. 
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2. Results 
According to a previously set strategy, literature searches resulted in 1405 articles, of which 25 met 
the inclusion criteria and were included in the final review after thorough analysis (Figure 1). A total  
of 22 in vitro studies and three clinical trials addressing the anti-caries properties of EOs and their 
isolated compounds were selected and will be further discussed herein. 
 
Figure 1. Flow diagram of the search strategy comprising the identification of potentially 
relevant material, and preliminary screening and final selection of the studies included in 
this review (based on PRISMA guidelines). * The leading reasons for exclusion of articles 
were: clinical trials—“score lower than 3 in Jadad’s scale” (see Methods); in vitro 
studies—lack of critical information on chemical profiling, and methodological shortcomings.  
2.1. In Vitro Studies 
According to the in vitro studies analyzed, there was a predominance of tests with planktonic 
cultures (Tables 1–6) rather than mono- or multi-species biofilm cultures (Table 7). Of the 22 studies, 
5 (22.72%) tested the effect of the EO on streptococci and lactobacilli biofilms. 
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2.1.1. Planktonic Studies 
Crude EOs and Planktonic S. mutans 
Thirty species were found to have very strong or strong antibacterial activity against S. mutans, of 
which the most promising were Achillea ligustica All. (ligurian yarrow) [19], Cryptomeria japonica D. 
Don (sugi) [20], Croton cajucara Benth (sacaca) [21], Baccharis dracunculifolia DC (broom weed), 
Coriandrum sativum L. (coriander), Lippia sidoides Cham. (rosemary-pepper), Mikania glomerata 
Sprengel (guaco) and Siparuna guianenses Aubl. (wild lemon) [11], with planktonic MIC values equal 
to or lower than 100 µg/mL (Table 1). 
Table 1. In vitro antibacterial activity of essential oils against Streptococcus mutans. 
Plant Species Source Microorganism MIC (µg/mL) MBC (µg/mL) Score Ref. 
Achillea ligustica All. Inflorescences DSM 20523 155 nt +++ [19] 
Achillea ligustica All. Leaves DSM 20523 155 nt +++ [19] 
Achillea ligustica All. flowering aerial parts DSM 20523 38 nt ++++ [19] 
Achillea ligustica All. Flowers DSM 20523 155 310 +++ [22] 
Achillea ligustica All.  vegetative parts DSM 20523 39 39 ++++ [22] 
Ageratum conyzoides Leaves ATCC 25175 4000 nt − [23] 
Aloysia gratissima Leaves UA 159 125–250 250–500 +++ [11] 
Aloysia triphylla Leaves UA 159 125–250 125–250 +++ [11] 
Alpinia speciosa Root UA 159 125–250 250–500 +++ [11] 
Artemisia camphorata Vill. Leaves ATCC 25175 2000 nt + [23] 
Baccharis dracunculifolia Leaves UA 159 62.5–125 250–500 ++++ [11] 
Bidens sulphurea Leaves ATCC 25175 250 nt +++ [23] 
Cinnamomum zeylanicum Leaves UA 159 250–500 500–1000 +++ [11] 
Coriandrum sativum Leaves UA 159 31.2–62.5 62.5–125 ++++ [11] 
Croton cajucara Benth  Leaves ATCC 4646 40.1 13.8 ++++ [21] 
Cryptomeria japonica aerial parts ATCC 25175 100 200 ++++ [20] 
Cuminum cyminum CS PTCC 1601 4000 nt − [24] 
Cymbopogon citratus Leaves UA 159 125–250 250–500 +++ [11] 
Cymbopogon martini leaves UA 159 125–250 250–500 +++ [11] 
Cymbopogon winterianus Leaves UA 159 125–250 250–500 +++ [11] 
Cyperus articulatus Bulbs UA 159 125–250 250–500 +++ [11] 
Elyonurus muticus Leaves UA 159 125–250 250–500 +++ [11] 
Eucalyptus radiate CS JC-2 10,000 10,000 − [25] 
Eugenia caryophyllata L. CS ATCC 25175 200 800 +++ [26] 
Eugenia caryophyllata L. CS ATCC 5175 600 nt ++ [27] 
Eugenia florida Leaves UA 159 125–250 125–250 +++ [11] 
Eugenia uniflora Leaves UA 159 125–250 250–500 +++ [11] 
Foeniculum vulgare Mill. Leaves ATCC 25175 >4000 nt − [23] 
Lavandula officinalis CS JC-2 >10,000 >10,000 − [25] 
Leptosperfum scoparium CS JC-2 2500 2500 − [25] 
Lippia alba Leaves ATCC 25175 500 nt +++ [23] 
Lippia alba Leaves UA 159 125–250 250–500 +++ [11] 
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Table 1. Cont. 
Plant Species Source Microorganism MIC (µg/mL) MBC (µg/mL) Score Ref. 
Lippia sidoides Leaves UA 159 62.5–125 125–250 ++++ [11] 
Melaleuca alternifólia CS JC-2 10,000 10,000 − [25] 
Melaleuca alternifólia Leaves clinical isolates 0.25–2 0.25–2 * [28] 
Mentha piperita Leaves UA159 250–500 250–500 +++ [11] 
Mentha piperita CS PTCC 1601 6000 nt + [24] 
Mikania glomerata Leaves UA 159 62.5–125 125–250 ++++ [11] 
Ocimum americanum L. Leaves ATCC 6363 0.04 0.08 * [29] 
Ocimum gratissimum L. Leaves ATCC 25175 1000 nt ++ [23] 
Pelargonium graveolens Leaves ATCC 25175 1000 nt ++ [23] 
Romarinus officinalis L. Leaves JC-2 >10,000 >10,000 − [25] 
Rosmarinus officinalis L. Leaves ATCC 25275 >2000 nt − [15] 
Rosmarinus officinalis L. CS PTCC 1601 2000 nt − [30] 
Satureja biflora flowering aerial parts clinical isolates 640 nt ++ [31] 
Satureja masukensis flowering aerial parts clinical isolates 570 nt ++ [31] 
Satureja pseudosimensis Leaves and flowering 
tops 
clinical isolates 920 nt ++ [31] 
Siparuna guianenses Leaves UA 159 62.5–125 125–250 ++++ [11] 
Syzygium aromaticum Leaves ATCC 25175 2000 nt + [23] 
Syzygium aromaticum Leaves UA 159 250–500 250–500 +++ [11] 
Tagetes erecta L. Leaves ATCC 25175 >4000 nt − [23] 
Thymus eriocalyx CS PTCC 1601 2000 nt + [30] 
Zivuphus zoazeiro Leaves UA 159 250–500 500–1000 +++ [11] 
Note: * values are expressed as v/v; CS (commercial source); nt (not tested); Comparative MIC values:  
(++++) <100; (+++) 101 to 500; (++) 501 to 1000; (+) >1001 to 2000; (−) >2001. 
Crude EOs and Planktonic S. sobrinus, S. sanguinis and S. salivarius 
Four plant species were found to have very strong or strong antibacterial activity against S. sobrinus, 
as follows: Croton cajucara Benth (sacaca) [21]; Rosmarinus officinalis L. (rosemary) [15]; Eugenia 
caryophyllata L. (clove) [26] and Cryptomeria japonica (sugi) [20]. Of these, C. japonica also had 
very strong and strong activity against S. sanguinis and S. salivarius, respectively (Table 2). 
Crude EOs and Planktonic Lactobacilli 
Achillea ligustica (ligurian yarrow) [19] had strong activity against L. acidophilus. Another species 
of Lactobacillus, L. casei, was found to be strongly susceptible to Croton cajucara (sacaca) [21], 
Artemisia camphorata Vill. (camphor), Bidens sulphurea Sch. Bip. (yellow cosmos), Lippia alba Mill. 
(lemon balm) and Ocimum gratissimum L. (tree basil) [23] (Table 3). 
EO-Isolated Compounds against Streptococci and Lactobacilli 
Menthol, isolated from Mentha longifolia L., and eugenol, isolated from Eugenia caryophyllata L., 
were found to be the most promising compounds with strong activity against streptococci and 
lactobacilli (Tables 4–6). 
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Table 2. In vitro antibacterial activity of essential oils against S. sobrinus, S. sanguinis and S. salivarius. 
Plant Species Source Microorg 
S. sobrinus 1 S. sanguinis 2 S. salivarius 3 
Ref. MIC 
(µg/mL)
MBC 
(µg/mL) 
Score 
MIC  
(µg/mL) 
MBC  
(µg/mL) 
Score 
MIC  
(µg/mL) 
MBC 
(µg/mL) 
Score 
Achillea ligustica All inflorescences IMC104 3 nt nt  nt nt  1250 nt + [19] 
Achillea ligustica All Leaves IMC104 3 nt nt  nt nt  1250 nt + [19] 
Achillea ligustica All flowering aerial parts IMC104 3 nt nt  nt nt  625 nt ++ [19] 
Ageratum conyzoides L. Leaves 
ATCC 33478 1 
>4000 nt − >4000 nt − 4000 nt − [23] ATCC 10556 2 
ATCC 25975 3 
Artemisia camphorata Vill. Leaves 
ATCC 33478 1 
2000 nt + 2000 nt + 4000 nt − [23] ATCC 10556 2 
ATCC 25975 3 
Bidens sulphurea Leaves 
ATCC 33478 1 
4000 nt − 4000 nt − 4000 nt − [23] ATCC 10556 2 
ATCC 25975 3 
Croton cajucara Benth Leaves ATCC 27609 1 13.8 nt ++++ nt nt  nt nt  [21] 
Cryptomeria japonica aerial parts 
ATCC 27607 1  
100 100 ++++ 100 200 ++++ nt nt  [20] 
ATCC 10556 2 
Eucalyptus radiate CS 
ATCC 6715 1 
10,000 10,000 − nt nt  nt nt  [25] 
ATCC B13 1 
Eugenia caryophyllata L. Flowers 
ATCC 27607 1  
200 800 +++ 400 800 +++ nt nt  [26] 
ATCC 10556 2 
Foeniculum vulgare Mill. Leaves 
ATCC 33478 1 
>4000 nt − >4000 nt − >4000 nt − [23] ATCC 10556 2 
ATCC 25975 3 
Lavandula officinalis CS 
6715 1  
B13 1 
10,000 
10,000 
10,000 
10,000 
−  
− nt nt  nt nt  [25] 
Leptosperfum scoparium CS 
6715 1  
B13 1 
1300 
2500 
2500  
2500 
+  
− nt nt  nt nt  [25] 
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Table 2. Cont. 
Plant Species Source Microorg 
S. sobrinus 1 S. sanguinis 2 S. salivarius 3 
Ref. MIC 
(µg/mL)
MBC  
(µg/mL) 
Score 
MIC  
(µg/mL) 
MBC  
(µg/mL) 
Score 
MIC  
(µg/mL) 
MBC 
(µg/mL) 
Score 
Lippia alba Leaves 
ATCC 33478 1 
1000 nt ++ 1000 nt ++ 2000 nt + [23] ATCC 10556 2 
ATCC 25975 3 
Melaleuca alternifólia CS 
6715 1  
B13 1 
10,000 
2500 
10,000 
10,000 
−  
− nt nt  nt nt  [25] 
Mentha piperita CS 
Ssb 176 1 
3000 nt − 6000 nt − nt nt  [32] 
Ssg 009 2 
Ocimum basilicum CS 
Ssb 176 1 
6000 nt − 6000 nt − nt nt  [32] 
Ssg 009 2 
Ocimum gratissimum L. Leaves 
ATCC 33478 1 
1000 nt ++ 2000 nt + 2000 nt + [23] ATCC 10556 2 
ATCC 25975 3 
Pelargonium graveolens Leaves 
ATCC 33478 1 
1000 nt ++ 2000 nt + 2000 nt + [23] ATCC 10556 2 
ATCC 25975 3 
Rosmarinus officinalis L. Leaves 
6715 1 10,000 
10,000 
10,000 
10,000 
−  
− nt nt  nt nt  [25] B13 1 
Rosmarinus officinalis L. Leaves 
ATCC 33478 1  
500 nt +++ >2000 nt − 600 nt ++ [15] ATCC 10556 2 
ATCC 25975 3 
Salvia officinalis CS 
Ssb 176 1 
3000 nt − 6000 nt − nt nt  [32] 
Ssg 009 2 
Syzygium aromaticum Leaves 
ATCC 33478 1 
>4000 nt − >4000 nt − >4000 nt − [23] ATCC 10556 2 
ATCC 25975 3 
Tagetes erecta L. Leaves 
Ssb 176 1 
6000 nt − nt nt  nt nt  [32] 
Ssg 009 2 
Note: CS = commercial source; nt (not tested); Comparative MIC values: (++++) <100; (+++) 101 to 500; (++) 501 to 1000; (+) >1001 to 2000; (−) >2001; 1 S. sobrinus;  
2 S. sanguinis and 3 S. salivarius. 
Molecules 2015, 20 7336 
 
 
Table 3. In vitro antibacterial activity of essential oils against lactobacilli. 
Plant Species Source Microorg 
L. acidophilus 1 L. casei 2 
Ref. MIC 
(µg/mL) 
MBC 
(µg/mL) 
Score 
MIC 
(µg/mL) 
MBC 
(µg/mL) 
Score 
Achillea ligustica All. Inflorescences IMC 101 1 310 nt +++ nt nt  [19] 
Achillea ligustica All. Leaves IMC 101 1 2500 nt − nt nt  [19] 
Achillea ligustica All. flowering aerial parts IMC 101 1 1250 nt + nt nt  [19] 
Ageratum conyzoides L. Leaves ATCC 11578 2 nt nt  4000 nt - [23] 
Artemisia camphorata Vill. Leaves ATCC 11578 2 nt nt  500 nt +++ [23] 
Bidens sulphurea Leaves ATCC 11578 2 nt nt  500 nt +++ [23] 
Croton cajucara Benth Leaves ATCC 4646 2 nt nt  22.3 nt ++++ [21] 
Foeniculum vulgare Mill. Leaves ATCC 11578 2 nt nt  4000 nt − [23] 
Lippia alba Leaves ATCC 11578 2 nt nt  500 nt +++ [23] 
Ocimum americanum L. Leaves ATCC 6363 2 nt nt  0.04 0.3 * * [29] 
Ocimum basilicum aerial parts ATCC 4356 1 80,000 nt − nt nt  [33] 
Ocimum gratissimum L. Leaves ATCC 11578 2 nt nt  500 nt +++ [23] 
Origanum vulgare aerial parts ATCC 4356 1 5000 nt − nt nt  [33] 
Pelargonium graveolens Leaves ATCC 11578 2 nt nt  1000 nt ++ [23] 
Rosmarinus officinalis aerial parts ATCC 4356 1 80,000 nt − nt nt  [33] 
Salvia officinalis aerial parts ATCC 4356 1 80,000 nt − nt nt  [33] 
Syzygium aromaticum Leaves ATCC 11578 2 nt nt  1000 nt ++ [23] 
Tagetes erecta L. Leaves ATCC 11578 2 nt nt  4000 nt − [23] 
Thymus vulgaris aerial parts ATCC 4356 1 5000 nt − nt nt  [33] 
Note: * values are expressed as % (v/v); nt (not tested); Comparative MIC values: (++++) <100; (+++) 100 to 
500; (++) 501 to 1000; (+) >1001 to 2000; (−) >2001; 1 L. acidophilus; 2 L. casei. 
Table 4. Essential oils isolated compounds against Streptococcus mutans. 
Compound Plant Species 
Culture 
Collection 
MIC  
(μg/mL) 
MBC  
(μg/mL) Score Ref. 
1,8, Cineole Achillea ligustica All DSM 20523 2500 nt − [19] 
1,8, Cineole Achillea ligustica All DSM 20523 155 1250 +++ [22] 
1,8, Cineole Rosmarinus officinalis ATCC 25275 1500 nt + [15] 
Camphor Rosmarinus officinalis ATCC 25275 1500 nt + [15] 
Caryophyllene oxide Satureja species clinical isolates 250 nt +++ [31] 
Eugenol Eugenia caryophyllata L. ATCC 25175 100 200 ++++ [26] 
Linalool Achillea ligustica All DSM 20523 625 nt ++ [19] 
Linalool Achillea ligustica All DSM 20523 310 310 +++ [22] 
Linalool Croton cajucara Benth ATCC 25175 no activity nt − [21] 
Linalool Satureja species clinical isolates 370 nt +++ [31] 
Menthol Mentha longifolia L. clinical isolates 15.6 nt ++++ [34] 
Pulegone Satureja species clinical isolates 1750 nt + [31] 
Sabinene Cryptomeria japonica ATCC 25175 800 1600 ++ [20] 
Terpinen-4-ol Achillea ligustica All DSM 20523 1250 nt + [19] 
Terpinen-4-ol Achillea ligustica All DSM 20523 310 625 +++ [22] 
Terpinen-4-ol Cryptomeria japonica ATCC 25175 1600 3200 + [20] 
Verbenone Rosmarinus officinalis ATCC 25275 1000 nt ++ [15] 
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Table 4. Cont. 
Compound Plant Species 
Culture 
Collection 
MIC  
(μg/mL) 
MBC  
(μg/mL) Score Ref. 
Viridiflorol Achillea ligustica All DSM 20523 2500 nt − [19] 
α-Pinene Cryptomeria japonica ATCC 25175 6400 28,000 − [20] 
α-Pinene Rosmarinus officinalis ATCC 25275 2000 nt + [15] 
α-Terpineol Cryptomeria japonica ATCC 25175 1600 3200 + [20] 
β-Caryophyllene Eugenia caryophyllata L. ATCC 25175 1600 3200 + [26] 
β-Caryophyllene Rosmarinus officinalis ATCC 25275 300 nt +++ [15] 
β-Myrcene Rosmarinus officinalis ATCC 25275 400 nt +++ [15] 
β-Pinene Achillea ligustica All DSM 20523 1250 nt + [19] 
β-Pinene Achillea ligustica All DSM 20523 625 1250 ++ [22] 
γ-Terpinene Achillea ligustica All DSM 20523 2500 nt − [19] 
Note: CS (commercial source); nt (not tested); Comparative MIC values: (++++) < 100; (+++) 100 to 500; 
(++) 501 to 1000; (+) > 1001 to 2000; (−) > 2001. 
Table 5. Essential oils isolated compounds against lactobacilli. 
Compound Source 
Culture 
Collection 
L. acidophilus 1 L. casei 2 
Ref. MIC 
(µg/mL)
MBC 
(µg/mL) 
Score
MIC 
(µg/mL) 
MBC 
(µg/mL) 
Score 
1,8, Cineole * Achillea ligustica All IMC101 1 5000 nt − nt nt  [19] 
Linalool Croton cajucara Benth ATCC 4646 2 nt nt  no activity nt − [21] 
Linalool * Achillea ligustica All IMC101 1 5000 nt − nt nt  [19] 
Menthol Mentha longifolia L. clinical isolates 31.2 nt ++++ nt nt  [34] 
Terpinen-4-ol * Achillea ligustica All IMC101 1 5000 nt − nt nt  [19] 
β-Pinene * Achillea ligustica All IMC101 1 2500 nt − nt nt  [19] 
γ-Terpinene * Achillea ligustica All IMC101 1 5000 nt − nt nt  [19] 
Note: * standard from Sigma-Aldrich® (St. Louis, MO, USA); nt (not tested); Comparative MIC values: 
(++++) <100; (−) >2001; 1 L. acidophilus; 2 L. casei. 
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Table 6. Essential oils isolated compounds against S. sobrinus, S. sanguinis and S. salivarius. 
Compound Plant Species 
Culture 
Collection 
S. sobrinus 1 S. sanguinis 2 S. salivarius 3 
Ref. MIC 
(µg/mL) 
MBC 
(µg/mL) 
Score 
MIC 
(µg/mL) 
MBC 
(µg/mL) 
Score 
MIC 
(µg/mL) 
MBC 
(µg/mL) 
Score 
1,8-cineole Achillea ligustica All IMC104 3 nt nt  nt nt  1250 nt + [19] 
Camphor Rosmarinus officinalis 
ATCC 33478 1 
1500 nt + 400 nt +++ 400 nt +++ [15] ATCC 10556 2 
ATCC 25975 3 
Eugenol Eugenia caryophyllata L. 
ATCC 27607 1 
200 400 +++ 400 800 +++ nt nt  [26] 
ATCC 10556 2 
Linalool Achillea ligustica All IMC104 3 nt nt  nt nt  625 nt ++ [19] 
Linalool Croton cajucara Benth ATCC 27609 1 no activity nt − nt nt  nt nt  [21] 
Sabinene Cryptomeria japonica 
ATCC 27607 1 
ATCC 10556 2 
200 200 +++ 400 400 +++ nt nt  [20] 
Terpinen-4-ol Achillea ligustica All IMC104 3 nt nt  nt nt  625 nt ++ [19] 
Terpinen-4-ol Cryptomeria japônica 
ATCC 27607 1 
1600 3200 + 1600 3200 + nt nt  [20] 
ATCC 10556 2 
Verbenone Rosmarinus officinalis 
ATCC 33478 1 
1000 nt ++ 400 nt +++ 400 nt +++ [15] ATCC 10556 2 
ATCC 25975 3 
Viridiflorol Achillea ligustica All IMC104 3 nt nt  nt nt  625 nt ++ [19] 
α-Pinene Cryptomeria japonica ATCC 27607 
1 
6400 12.800 − 6400 6400 - nt nt  [20] 
ATCC 10556 2 
α-Pinene Rosmarinus officinalis 
ATCC 33478 1 
1000 nt ++ 400 nt +++ 400 nt +++ [15] ATCC 10556 2 
ATCC 25975 3 
α-Terpineol Cryptomeria japônica ATCC 27607 
1 
1600 1600 + 1600 3200 + nt nt  [20] 
ATCC 10556 2 
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Table 6. Cont. 
Compound Plant Species 
Culture 
Collection 
S. sobrinus 1 S. sanguinis 2 S. salivarius 3 
Ref. MIC 
(µg/mL) 
MBC 
(µg/mL) 
Score 
MIC 
(µg/mL) 
MBC 
(µg/mL) 
Score 
MIC 
(µg/mL) 
MBC 
(µg/mL) 
Score 
β-Caryophyllene Eugenia caryophyllata L. ATCC 27607 
1 
12,800 12,800 − 1600 3200 + nt nt  [26] 
ATCC 10556 2 
β-Caryophyllene Rosmarinus officinalis 
ATCC 33478 1 
400 nt +++ 400 nt +++ 400 nt +++ [15] ATCC 10556 2 
ATCC 25975 3 
β-Myrcene Rosmarinus officinalis 
ATCC 33478 1 
1500 nt + 1500 nt + 400 nt +++ [15] ATCC 10556 2 
ATCC 25975 3 
β-Pinene Achillea ligustica All IMC104 3 nt nt  nt nt  625 nt ++ [19] 
γ-Terpinene Achillea ligustica All IMC104 3 nt nt  nt nt  625 nt ++ [19] 
Note: nt (not tested); Comparative MIC values: (+++) 100 to 500; (++) 501 to 1000; (+) >1001 to 2000; (−) >2001; 1 S. sobrinus; 2 S. sanguinis and 3 S. salivarius.  
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2.1.2. Biofilm Studies 
Crude EOs and Biofilms of Streptococci and Lactobacilli 
A total of eight species were tested against biofilm cultures of S. mutans, S. sobrinus and/or L. casei 
using different assays (Table 7). Interestingly, bioactive fractions of C. sativum and B. dracunculifolia 
inhibited 90% of S. mutans biofilm formation at concentrations as low as 31.2 μg/mL. Moreover,  
C. cajucara EO (100 μg/mL) and O. americanum EO (3%) inhibited S. mutans and L. lactis biofilms 
as effectively as chlorhexidine, used as positive control. 
Overall, the majority of studies in this review tested the effectiveness of EO against S. mutans (35 
out of 40 studies), followed in lower proportions by S. sobrinus, S. salivarius, S. sanguinis and 
Lactobacillus spp. As seen in Table 8, just a few studies carried out a comprehensive analysis of the 
effect of EO against a broad panel of caries-related species. 
2.2. In Vivo Studies 
Randomized Clinical Trials 
Three high quality randomized, double-blind clinical trials of herbal interventions with low risk of 
bias were included in this review (Figure 2). The EOs from L. sidoides [35,36] and a multi-herbal 
formulation including Melaleuca alternifolia and Leptospermum scoparium oils (combined with Calendula 
officinalis and Camellia sinensis extracts) [37], were tested in humans for their effectiveness in 
reducing the amount of cariogenic biofilm, measured by means of plaque indexes. The experimental 
period of studies ranged from 1 week to 12 weeks, with different assessment checkpoints and dosing 
protocols. As seen in Table 9, only individuals treated with 1% L. sidoides EO mouthwash had a 
statistically significant reduction in their supragingival biofilm levels compared to chlorhexidine group 
(positive control) and to their baseline condition. 
2.3. Chemical and Botanical Characterization and Georeferencing of the most Promising  
Bioactive EOs 
Viridiflorol, terpinen-4-ol and β-pinene are found in the EO from all parts [19,22] of A. lingustica; 
however, important terpenes such as linalool, 1,8-cineole and germacrene D have also been identified 
in specific parts of the plant. Elemol, terpinen-4-ol, sabinene, 10(15)-cadinen-4-ol, α-terpineol and  
α-pinene are the major compounds identified in C. japonica [20]. Linalool is the most abundant 
compound of C. cajucara Benth [21]. Trans-nerolidol, spathulenol and trans-caryophyllene are found 
in B. dracunculifolia [11]. 1-decanol, trans-2-decen-1-ol and 2-dodecen-1-ol are the most abundant 
compounds of C. sativum [11]. Thymol is the major compound of L. sidoides [11]. Camphor, 
verbenone, α-pinene, β-myrcene, 1,8-cineole and β-caryophyllene are found in R. officinalis [15]. 
Eugenol and β-caryophyllene are the major compounds of E. caryophyllata [26].  
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Table 7. Essential oils, fractions or isolated compounds against in vitro oral biofilm formation. 
Ref. 
Essential Oil/Fraction or 
Isolated Compound 
Biofilm Formation 
Strain Test(s) Performed Biofilm Age Conditions Outcomes 
[11] 
Aloysia gratíssima (Ag), 
Coriandrum sativum (Cs) and 
Baccharis dracunculifolia (Bd) 
fraction 
S. mutans UA159 
Formation of S. mutans biofilm, the 
samples were placed in the wells of sterile 
polystyrene U-bottom microtiter plates, 
previously treated with saliva 
S. mutans cells (1.0 × 107 cells/mL in BHI 
medium) were added to wells containing BHI 
medium with 2% sucrose and the samples 
were incubated at 37 °C for 18 h 
Biofilm of Cs4 and Bd2 fractions presented a better 
performance since they inhibited more than 90% of 
biofilm formation at lower concentrations (31.2 μg/mL). 
[21] Croton cajucara Benth leaves S. mutans ATCC 25175 
Macro technique using microbial disks 
subjected to the action of the essential oil 
and controls 
The biofilms were exposed to controls and 
essential oil for 3 min and incubated for 72 h 
at 37 °C 
Growth inhibition: EO 70%–75% 
Chlorhexidine 65%–70% 
[21] Croton cajucara Benth leaves 
S. sobrinus  
ATCC 27609 
Macro technique using microbial disks 
subjected to the action of the essential oil 
and controls 
The biofilms were exposed to controls and 
essential oil for 3 min and incubated for 72 h 
at 37 °C 
Growth inhibition: EO 75%–80% 
Chlorhexidine 50%–55% 
[21] Croton cajucara Benth leaves L. casei ATCC 4646 
Macro technique using microbial disks 
subjected to the action of the essential oil 
and controls 
The biofilms were exposed to controls and 
essential oil for 3 min and incubated  
for 72 h at 37 °C 
Growth inhibition: EO 80%–85% 
Chlorhexidine 65%–70% 
[38] Curcuma longa root S. mutans ATCC 25175 
Technique using 24-well plates containing 
resin teeth. 
After cultivating S. mutans for 24 h at 37 °C, 
the supernatant was removed, and the wells 
were rinsed with distilled H2O. Biofilm 
formation in the wells was measured by 
staining with 0.1% safranin 
Biofilm formation was decreased in the presence of  
C. longa essential oil at concentrations higher  
than 500 µg/mL 
[39] 
Mentha piperita and 
Rosmarinus officinalis 
S. mutans PTCC 1601 Biofilm formation (SBF) assay 
The biofilms were exposed to controls  
and essential oil and incubated for 17 ± 1 h  
at 37 °C 
M. piperita and R. officinalis oils effectively inhibited  
S. mutans biofilm at 6000 and 2000 ppm, respectively. 
[29] Ocimum americanum L. leaves S. mutans KPSK2 
Microtiter technique Protocol  
using saliva. 
The biofilms were exposed to controls and 
essential oil (0.3% and 3% v/v) for 5 min and 
incubated for 24 h 
EO 0.3% (v/v) 7.2 × 104 CFU/mL; EO 3% (v/v)  
2.9 × 103 CFU/mL; 0.2% Chlorhexidine:  
1.7 × 103 CFU/mL; Saline solution 8.5.106 CFU/mL 
[29] Ocimum americanum L. leaves L. casei ATCC 6363 Microtiter technique Protocol using saliva. 
The biofilms were exposed to controls and 
essential oil (0.3% and 3% v/v) for 5 min and 
incubated for 24 h 
EO 0.3% (v/v) 5.1 × 105 CFU/mL; EO 3% (v/v)  
6.3 × 103 CFU/mL; 0.2% Chlorhexidine:  
2.5 × 103 CFU/mL; Saline solution 6.0 × 106 CFU/mL 
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Table 8. Framework of studies. Distribution of promising EOs and their isolated constituents 
tested against caries-related bacteria. 
Plant Species or 
Chemical Constituent 
Antibacterial Efficacy 
Planktonic Cells Biofilms 
Clinical Trial 
Smu Ssob Ssan Ssal Lc La Smu Ssob Ssal Lc 
A. ligustica + 
B. dracunculifolia + 
C. cajucara + +  + + + + 
C. japonica + + +        
C. sativum + 
E. caryophyllata + + + 
L. sidoides + Plaque reduction 
O. americanum + + + + 
Menthol + + 
Eugenol + + + 
Note: (+): MIC <100 µg/mL or correspondent; Smu: S. mutans; Ssob: S. sobrinus; Ssan: S. sanguinis;  
Ssal: S. salivarius; Lc: L. casei; La: L. acidophilus. 
 
Figure 2. Risk-of-bias summary of the clinical trials included in this systematic review. 
Red (−) stands for high risk of bias, green (+) stands for low risk of bias and yellow (?) 
stands for unclear risk of bias. Overall, the studies are compliant with the CONSORT 
guidelines for clinical trials of herbal interventions, showing low risk of bias. 
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Table 9. Characteristics of the Randomized Clinical Trials included in this systematic review. 
Plant Species 
Essential Oil 
Formulation 
Study Design Sample Size Country 
Age (Mean ± 
SD)/Gender 
(Fem) * 
Sample 
Loss/Reasons 
Control 
Group 
Dosing Protocol 
Assessment 
Checkpoints 
Assessment 
Instruments of 
Interest 
Outcome ** Ref. 
Lipia sidoides 
1% L. sidoides 
mouthrinse 
Phase II, 
randomized, 
double-blind, 
crossover 
n = 55 (n = 27  
L. sidoides 
group; n = 28 
control group) 
Brazil 
31 ± 10.90 
55.6% F 
16 individuals  
(no gender 
distinction)/lack of 
compliance or 
could not be 
reached for  
follow-up visits. 
0.12% CHX 
Rinsing approx.  
15 mL for 30 s, 
twice a day (once 
after breakfast and 
once in the late 
afternoon) during  
a 7-day period. 
Baseline,  
1 week 
Plaque index (PI) 
measured at four 
sites per tooth 
(Ainamo & Bay, 
1975) 
+/+ [35] 
Lipia sidoides 
10%  
L. sidoides gel 
Phase II, 
randomized, 
double-blind, 
crossover. 
Partial mouth 
experimental 
model 
n = 26 (n = 13 
L. sidoides 
group; n = 13 
control group) 
Brazil 
22 ± 4.24 
50.0% F 
4 individuals  
(no gender 
distinction)/third 
molar extraction 
Placebo gel 
Filling a toothshield 
with the gel prior to 
insertion in the 
mouth and  
seating it over the 
experimental teeth 3 
times a day for at 
least 1 min. 
Baseline,  
3 weeks 
Plaque index (PI) 
measured at six 
sites per tooth 
(Turesky et al., 
1970) 
−/+ [36] 
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Table 9. Cont. 
Plant Species 
Essential Oil 
Formulation 
Study Design Sample Size Country 
Age (Mean ± 
SD)/Gender 
(Fem) * 
Sample 
Loss/Reasons 
Control 
Group 
Dosing Protocol 
Assessment 
Checkpoints 
Assessment 
Instruments of 
Interest 
Outcome ** Ref. 
Melaleuca 
alternifolia, 
Leptospermum 
scoparium, 
Calendula 
officinalis and 
Camellia 
sinensis 
Multi-herbal 
mouthrinse 
containing 
0.67% (v/v) M. 
alternifolia oil, 
0.33% (v/v) M. 
scoparium oil, 
1% (v/v) C. 
officinalis flower 
extract (1:2) 
liquid extract  
[90% E/W]), 
0.5% (w/v) C. 
sinensis extract 
(dry extract, 80% 
polyphenols) and 
12.8% ethanol in 
water. 
Phase I and II, 
randomized, 
double-blind 
Phase I  
n = 8 
(experimental 
group)  
Phase II n = 20 
(n = 10 experim. 
group; n = 10 
control group) 
USA 
31.88 ± 7.51  
Phase I:  
62.5% F 
Phase II: 
82.3% F 
Phase I:  
1 female/reported 
mild ‘hay  
fever’-like 
symptoms. Her 
symptoms were 
judged to be 
unrelated to the 
mouthrinse. 
Phase II:  
3 female/One 
reported 
lightheadedness 
(possibly related to 
the test rinse); One 
dropped out to 
participate in 
another study; and 
one was excluded 
because she 
required treatment 
with antibiotics for 
an unrelated 
condition. 
Placebo 
mouth rinse 
Rinsing approx.  
15 mL for 30 s,  
twice a day during  
a 6-week period. 
Baseline,  
6 weeks and 
12 weeks 
Plaque index (PI) 
measured at six 
sites per tooth 
(Quigley & Hein, 
1962) 
−/− [37] 
Note: CHX (chlorhexidine) mouthrinse; * Age and gender of individuals assigned to the experimental group; ** Statistically significant reduction (+) or not (−) in the 
amount of cariogenic biofilm compared to CHX or placebo (fist sign) and to the baseline condition (second sign, after slash) (p < 0.05). 
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The EO from A. camphorata, B. sulphurea, L. alba, M. glomerata, O. gratissimum and S. guianenses 
were not chemically characterized by the studies included in this review. Therefore, 21.7% of the 
selected studies had no chemical control regarding the EO under test. Furthermore, only 60.8% of the 
studies proceeded with a botanical identification of the aromatic plants that served as source for the 
EO. Finally, only 56.52% of the studies showed any piece of information about georeferencing of the 
plant species and 47.82% reported the period of plant collection. 
3. Discussion 
Essential oils have stood out as a promising source of bioactive molecules with potential application 
in the management of dental caries [40,41]. The data presented in this review suggest potential EO and 
constituents to be further tested as bioactive ingredients of anti-caries formulations. Moreover, the 
results of the reported chemical assessments of EO-isolated compounds could lead them to be used as 
chemical markers in future screening. Surprisingly, 20% and 60% of the studies do not provide any 
chemical or botanical information, respectively, which inevitably results in a biased and inconclusive 
analysis with reproducibility and traceability issues. Also, despite an understanding of the biological and 
physicochemical processes associated with the aetiopathogenesis of dental caries [8], great part (88%) 
of the current evidence on the anti-caries potential of EO is based on in vitro studies rather than 
clinical trials (see Section 3.3 in this Discussion). Altogether, the benefits and issues related to EO 
research suggest wide avenues for scientists to work on more comprehensive and trustworthy 
bioprospection studies. 
According to our searches, the majority of in vitro studies have evaluated the effect of EO or 
isolated compounds against S. mutans, as expected. Considered the most cariogenic of the oral 
streptococci, S. mutans colonizes the tooth surfaces and produces significant amounts of extra- and 
intra-cellular polysaccharides [42], being responsible for the initial stage of oral biofilm formation and 
carious lesions [43]. Nevertheless, other streptococci and lactobacilli species are also implicated on the 
onset [44] and progression [45] of caries, respectively, thus playing a role in the aetiopathogenesis of 
this biofilm-dependent disease. An EO of interest to be included in a formulation should be that able to 
affect bacterial virulence without suppressing the resident oral species, as a more specific therapeutic 
approach [8]. However, most studies provide just preliminary evidence of anti-caries activity without 
further assessing the effects of EO on putative virulence factors in cariogenic bacteria (e.g., 
glycosyltransferase and F-ATPase activity). In addition, the cariogenic biofilm is composed of a  
multi-species microbial community, in which the predominance of different microorganisms is 
changed as a function of host, diet and microorganism factors [46]. These aspects are not considered in 
most studies evaluating only planktonic cultures and, at most, monospecies biofilm cultures. 
Next, we provide a brief summary of the plant species whose EO and their isolated compounds 
were found to have significant in vitro anti-caries potential. Attention is given to the 
ethnopharmacological knowledge, biological properties and chemical composition. Despite our 
attempts to make inter-study comparisons, there are underlying distinctions related to extraction 
methods, georeferencing, seasonality, which should be taken into account. 
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3.1. Promising Essential Oils against Cariogenic Bacteria 
Achillea ligustica (Asteraceae) is a small herbaceous plant rich in terpenes that grows in the 
Mediterranean region and has been used in folk medicine mainly for the treatment of gastrointestinal 
disorders [47]. The EO from different parts of this plant (inflorescences, leaves and flowers) is also 
found to have antimicrobial activity, particularly against S. mutans [19,22]. However, as it can be seen 
in this review, when the major compounds of A. ligustica EO are tested alone (e.g., γ-terpinene,  
β-pinene, 1,8-cineole, terpinen-4-ol), there is a decrease in their antimicrobial activity, which suggests a 
synergistic effect of the compounds present in the whole EO. Different EOs from the genus Achillea 
have been used in the cosmetic and liqueur industry as fragrances and flavoring agents, demonstrating 
commercial and economic relevance [22]. 
Baccharis dracunculifolia (Asteraceae) a native plant from Brazil, is widespread in the tropical areas 
of South America and is the botanical source of Southeastern (or green) propolis [48]. It has been 
widely used in folk medicine as febrifuge, anti-inflammatory, antiseptic and in the treatment of skin sores 
and gastrointestinal disorders [49]. The trans-nerolidol- and spathulenol-rich EO from B. dracunculifolia 
and its active fractions are bacteriostatic and have an in vitro anti-cariogenic activity by disrupting  
S. mutans biofilm at concentrations as low as 31.25 µg/mL [11]. 
Croton cajucara (Euphorbiaceae) is a common shrub growing in the Amazonian region commonly 
used in folk medicine as a tea for ailments such as diarrhea, diabetes and gastrointestinal disorders [50]. 
Alviano et al. [21] found that the EO of C. cajucara has significant antibacterial activity against  
S. mutans, S. sobrinus and L. casei in planktonic and monospecies biofilm cultures, unlike its isolated 
major compound linalool. This result disagrees with others reported in this review showing that 
linalool is considerably active against S. mutans [19,22,31]; however, it remains controversial. 
Cryptomeria japonica (Cupressaceae) is an endemic and widely distributed coniferous plant in 
Japan, normally used for forestry, whose EO has been reported to have several pharmacological 
properties including larvicidal [51], antiulcer [52], antifungal [53] and antibacterial [20]. C. japonica 
EO is another example of how the complex mixture of chemical molecules plays a synergistic role in 
the antibacterial power of the EO over its isolated major compounds (sabinene, terpinen-4-ol, α-pinene 
and α-terpineol) [20]. In this review, we found significant inhibitory effects of the leaf EO against 
caries-related streptococci, warranting further investigation. 
Coriandrum sativum (Apiaceae) popularly known as coriander, is an annual small plant whose 
leaves and seeds are widely used in folk medicine as anti-hypertensive, cholesterol-lowering and 
digestive stimulant [54], and also as food condiment. Moreover, other biological properties of  
C. sativum EO have also been reported: antifungal [55,56] antibacterial [11,56], antioxidant [57] and 
hepatoprotective [58]. The EO from C. sativum leaves contains mostly decanal, trans-2-decenal and  
2-decen-1-ol [55], and has been shown to have in vitro anti-cariogenic potential against S. mutans 
biofilms and to be more active than its chemical fractions [11]. 
Eugenia caryophyllata (Myrtaceae) is widely cultivated in Indonesia, Sri Lanka, Madagascar, 
Tanzania and Brazil. E. caryophyllata EO (clove) has been described as having useful antiseptic, 
analgesic and anaesthetic effects. In community medicine, it serves as a topical pain-relieving and 
healing agent and in the industry as a fragrance and flavoring substance [59]. The main compounds of 
clove oil are phenylpropanoids such as eugenol and β-caryophyllene. According to our findings, 
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eugenol was proven to be more active than the EO against S. mutans, i.e., showed lower MIC values. 
Nevertheless, the crude EO of E. caryophyllata, in general, showed strong antimicrobial activity 
against streptococci. 
Lippia sidoides (Verbenaceae) is a typical shrub commonly found in the Northeastern Brazil, 
popularly used as topic skin and mucosal antiseptic [60]. L. sidoides EO also has anti-inflammatory, 
antioxidant and gastroprotective properties [61]. Its antimicrobial activity against cariogenic bacteria 
has been correlated with the presence of the phenolic monoterpenes thymol and carvacrol [62], and it 
may be considered of the most scientifically explored medicinal plants in Brazil, whose studies have 
reached the clinical phase. According to this review, L. sidoides EO showed both strong in vitro 
antibacterial activity and clinical efficacy as a mouthwash (see Section 3.3 in this Discussion), thus 
being considered a promising anti-plaque and anti-gingivitis phase II agent [37]. 
Ocimum americanum (Lamiaceae) popularly known as hoary basil, is an annual herbaceous plant 
native to Asia and Africa. O. americanum EO is reported to have anti-inflammatory, antinociceptive [63], 
antibacterial and insecticidal properties [64], and it is considered valuable for the cosmetic industry of 
soups and perfumes. The findings of this review showed that the leaf EO has strong antimicrobial 
activity against S. mutans and L. casei, either planktonic or biofilm cultures. The study by Thaweboon 
and Thaweboon [29] indicated that the 3% leaf EO is as effective as 0.2% chlorhexidine in reducing 
the bacterial counting of cariogenic biofilm cultures of S. mutans and L. lactis, thus highlighting its 
potential as an antiseptic agent for oral care. Other studies in vitro and in vivo are now encouraged to 
elucidate its effects on other aspects related to the aetiopathogenesis of tooth decay (e.g., 
glucosyltransferase activity, acid production, enamel demineralization, among others). 
Rosmarinus officinalis (Lamiaceae) is a culinary evergreen shrub native to the Mediterranean region 
that has also been used for medicinal purposes to treat bacterial and fungal infections [65]. Unlike the 
other cases presented thus far, the major compounds of R. officinalis EO (camphor, verbenone,  
α-pinene, β-myrcene, 1,8-cineole and β-caryophyllene) showed better activity (lower MIC value) against 
cariogenic bacteria—particularly S. sobrinus and S. salivarius—than the crude EO. 
3.2. Promising Compounds Isolated from Essential Oils against Cariogenic Bacteria 
Generally, the major phytochemical compounds determine the biological properties of EOs [66].  
In these cases, the study of isolated compounds is meaningful to concentrate the active principle, 
enable industrial scale production and allow improvements in the chemical structure using molecular 
engineering approaches. Here, we provide a summary on menthol and eugenol as the most outstanding 
compounds isolated from EOs that possess an anti-caries potential.  
Menthol is a compound that has raised interest of the pharmaceutical and food industry in the last 
decades. It is a terpenoid that can be found in the EO of the Mentha spp. genus, such as peppermint, 
with a crystalline, clear or white-colored aspect (Figure 3). Although there are several isomers of 
menthol available, only (‒)-menthol occurs in nature [34].  
In vitro [34,67] and in situ [68] studies have demonstrated that menthol inhibits the growth of both 
Gram-positive and -negative bacteria and yeasts, and that its mechanism of action may be related to 
membrane disruption leading to cell leakage. A number of clinical trials [18] have also supported the 
use of this compound as an ingredient of mouthwash formulations; some of which are already 
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commercially available worldwide. Although menthol has been used more as a flavoring agent than an 
active principle, it has been proven to have a considerable antimicrobial activity and is considered as 
GRAS (Generally Regarded as Safe) by the FDA (US Food and Drug Administration). 
 
Figure 3. The chemical structure of (‒)-menthol [(1R,2S,5R)-2-isopropyl-5-methylcyclohexanol]. 
Eugenol is an amphipathic phenolic compound (Figure 4) representing the major constituent of EO 
from clove (Eugenia caryophillis) and cinnamon (Cinnamomum zeylanicum) leaves [12]. Eugenol has 
been reported to have antiseptic, antimicrobial, anesthetic, analgesic, antioxidant, anti-inflammatory, 
and cardiovascular activities [69]. In dentistry, it is used as component of a cement containing zinc 
oxide for provisional sealing of cavities or as base for definitive fillings [70]. According to our review, 
eugenol has a promising antimicrobial activity against streptococci, particularly S. mutans, and should 
be considered as an anti-cariogenic agent to further clinical testing. It is an interesting source of new 
drugs as it is classified as GRAS by the FDA. This compound has been commercially marketed. 
 
Figure 4. The chemical structure of eugenol [4-Allyl-2-methoxyphenol]. 
In addition to these three compounds, some others indicated in this review arouse attention for their 
antibacterial power with MIC values lower than 500 µg/mL, as follows: 1,8, cineole, terpinen-4-ol, 
linalool, β-myrcene, β-caryophyllene and caryophyllene oxide. As such, the presence of these 
compounds in the EO of a plant could predict its antibacterial properties. 
3.3. Rational Clinical Use of Essential Oils and Isolated Compounds 
Despite the large number of in vitro studies on the antimicrobial activity of EOs, just a few reach 
the clinical phase and even fewer lead to a commercial product. Indeed, there is a small number of 
clinical trials reported in the literature aiming at the development of an EO-containing dental formulation. 
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The most effective way to use the majority of EOs is by external application, such as mouthwashes 
for dental care. Topical application is generally safe [66] because most compounds are considered as 
GRAS by the FDA and have been long used in food preparation in several cultures. In case of eventual 
oral administration of a mouthwash, for instance, most EO compounds (such as (−)-menthol, thymol, 
carvacrol and eugenol) would be excreted renally or exhaled via the lungs [71,72], and their fast 
metabolism and short half-life highlight a minimal risk of accumulation in the organism [73]. However, 
although EOs have the advantage of being usually devoid of long-term cytotoxicity and genotoxic 
risks [12], the high volatility and chemical instability of some of their compounds in the presence of 
heat, humidity, light, or oxygen, may negatively impact their clinical use [74]. 
At the present time, the most popular EO-based formulation used in dental care in Western society 
is composed of a fixed combination of four EO-derived active ingredients: thymol (0.064%), 
eucalyptol (0.092%), methyl salicylate (0.060%) and menthol (0.042%). It is considered effective against 
cariogenic bacteria and relatively safe, although its 21%–27% alcoholic formula used to keep the 
constituents in solution is still controversial [75]. In some cases, such as with A. ligustica [19,22],  
C. japonica [20] and C. sativum [56], the synergism of compounds in the EO is critical for its 
biological properties as opposite to its isolated constituents. Such chemical complexity may favor 
solubility in vehicles other than ethanol (e.g., propylene glycol), with less likelihood of adverse effects. 
According to our analysis, the mouthwash of thymol- and carvacrol-rich L. sidoides EO (ethanol-free) 
rinsed twice a day is an effective agent to prevent/disrupt the accumulation of cariogenic biofilm [36]. 
Furthermore, in a previous systematic review [76] we also found that such experimental mouthwash 
was effective against biofilm-induced gingivitis in adults. Altogether, these findings highlight the 
therapeutic potential of L. sidoides EO for dental care, but it is important to note that further studies are 
needed to investigate its effects on other aspects related to tooth decay, such as bacterial acid 
production, biofilm formation, enamel de- and remineralization, inhibition of glycosyltransferase 
production/activity, among others. Furthermore, the 10% gel of thymol- and carvacrol-rich L. sidoides 
EO was not effective to reduce the amount of biofilm in adults compared to a placebo [37], suggesting 
that the pharmaceutical preparation plays a crucial role in this clinical outcome. 
The synergistic association of EOs with other topical agents, e.g., fluoride, should also be 
considered for the management of dental caries, combining both antimicrobial and remineralization 
properties. A study by Zero et al. [77] showed that an EO mouthrinse with 100 parts per million 
fluoride should be effective in promoting enamel remineralization and fluoride uptake, thus providing 
anti-caries efficacy. 
In dentistry, EOs could be useful as preoperative rinses, in periodontal procedures (e.g., sub-gingival 
irrigation), post-treatment applications, as a conventional mouthwash etc. Nevertheless, the majority of 
studies in the literature up to date fail to indicate robust and translational data to support the clinical 
use of novel EOs as ingredients of dental formulations, particularly against dental caries. With that 
said, this review suggests further research on the EOs and their constituents described earlier due to 
their favorable potential against streptococci and lactobacilli. In addition, it is important to determine 
the effects of EO on bacterial virulence factors related to dental caries, such as synthesis of 
extracellular polysaccharides and ability to survive in and produce acidic environments [8]. The 
scientific validation of the anti-caries activity of EOs and isolated compounds could provide not only 
patentable preparations and advances in preventive dentistry, but also commercial value. 
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4. Methods 
4.1. Focused Question 
The aim of the present review was to answer the specific question: “Based on the current literature, 
which essential oils and/or isolated compounds are promising anti-caries agents warranting further 
investigation for clinical use?” 
4.2. Search Strategy and Selection of the Studies  
This systematic review of scientific studies followed the guidelines of the Transparent Reporting of 
Systematic Reviews and Meta-Analyses (PRISMA statement) [78]. Seven databases were systematically 
searched for clinical trials and in situ, in vivo and vitro studies (Table 10). 
Table 10. Search strategy and bibliographic databases used to retrieve the articles falling 
into the scope of this systematic review. 
Bibliographic Databases 
(Primary Sources) 
Search Strategy (Descriptors and Boolean Operators) 
SciVerse Scopus (Since 1995 
until December 2014) 
• (oils, volatile OR essential oil) AND (anti caries OR anti caries agents) 
• (oils, volatile OR essential oil) AND (mouthwashes OR dentifrice OR gel) AND anti plaque 
• (oils, volatile OR essential oil) AND (oral pathogens OR cariogenic bacteria) 
• (oils, volatile OR essential oil) AND antimicrobial AND oral cavity 
• essential oils AND oral 
Web of Science (Refine: 
article or review) (Since 1990 
until December 2014) 
• (oils, volatile OR essential oil) AND (anti caries OR anti caries agents) 
• (oils, volatile OR essential oil) AND (mouthwashes OR dentifrice OR gel) AND anti plaque 
• (oils, volatile OR essential oil) AND (oral pathogens OR cariogenic bacteria) 
Medline via Pubmed (Since 
1966 until December 2014) 
• (oils, volatile OR essential oil) AND (anti caries OR anti caries agents) 
• (oils, volatile OR essential oil) AND (mouthwashes OR dentifrice OR gel) AND anti plaque 
• (oils, volatile OR essential oil) AND (oral pathogens OR cariogenic bacteria) 
• (oils, volatile OR essential oil) AND antimicrobial AND oral cavity 
• essential oil AND oral cavity AND antibacterial 
• essential oil AND MIC AND oral 
SciELO (Scientific Electronic 
Library Online) (Since 1998 
until December 2014) and 
LILACS (Latin American and 
Caribbean Health Sciences 
Literature) (Since 1982 until 
December 2014) 
• aceites esenciales 
• aceite volatile 
• essential oil AND caries 
• óleo essencial AND Streptococcus mutans 
• óleo essencial AND Lactobacillus 
• óleo essencial AND oral 
• óleo essencial AND antibacteriano 
Cochrane Library 
• essential oil AND caries 
• óleo essencial AND Streptococcus mutans 
• óleo essencial AND Lactobacillus 
• óleo essencial AND oral 
• óleo essencial AND antibacteriano 
Google Scholar • Manual searches according to the reference lists of the articles 
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4.3. Eligibility Criteria 
A systematic selection of the articles was carried out by three independent examiners based on the 
following inclusion criteria: (1) Biological activity: anti-caries activity against oral microorganisms 
involved in the etiology and progression of dental caries; (2) Plant material and chemical assessment: 
essential oils and/or isolated compounds from aromatic plants (their chemical assessment was not  
a restricted inclusion criteria, instead, it served as a point for discussion); (3) Study design: In vitro,  
in situ and/or in vivo laboratorial studies (planktonic and biofilm assays); randomized controlled 
clinical trials (outcome of interest: reduction in the amount of cariogenic biofilm); (4) Methodological 
quality: For clinical trials, Jadad scale [79] equal to or greater than 3, meeting high quality standards 
(see Section 4.4 for details); accuracy of outcomes; internal and external validity; (5) Language: 
Articles written in English, Spanish or Portuguese; (6) Novelty: Novel essential oils-containing dental 
formulations were included, if not currently marketed. Examiners agreed that in cases of inconsistence 
the final verdict on which articles should be included in this review would be reached by consensus. 
4.4. Data Pooling and Analysis 
The data were allocated into worksheets to proceed with exploratory analysis according to the study 
design. For in vitro studies, in order to standardize the susceptibility patterns of microorganisms to 
essential oils or isolated compounds, we used their minimum inhibitory concentration (MIC) range as  
a parameter to determine the intensity of antibacterial activity, based on the literature [80] and on our 
research experience (Table 11). The retrieved data were expressed according to the bacterial species 
related to different types of tooth decay, in terms of selectivity to specific surfaces: Streptococcus mutans 
(sulcus and fissure, smooth surface caries—main etiological agent of dental caries) [81]; S. sanguinis, 
S. sobrinus, S. salivarius play a secondary role and may be recovered from sulcus, fissure and smooth 
surface caries [82]; Lactobacillus spp. (dentin and root surface caries) [45], either in planktonic or 
biofilm assays. 
Table 11. Established parameters based on Minimum Inhibitory Concentrations of 
essential oils or related chemical constituents.  
MIC Range Intensity of Antibacterial Activity Score 
<100 µg/mL very strong activity (++++) 
101–500 µg/mL strong activity (+++) 
501–1000 µg/mL moderate activity (++) 
1001–2000 µg/mL weak activity (+) 
>2001 µg/mL no activity (−) 
For clinical trials, the data were analyzed based on the CONSORT guidelines for reporting 
randomized, controlled trials of herbal interventions [83]. Jadad Scale [79] has also been adopted in 
this review as it checks the validity of evidence on interventions and evaluates methodological quality 
(randomization, blinding and loss of follow-up). Based on these criteria, we assigned scores to the 
studies ranging from 0 to 5. Studies reaching a score <3 were considered of poor quality and thus 
excluded from this review. Several studies, including systematic reviews, have already embraced  
Molecules 2015, 20 7352 
 
 
this validated evaluation tool [84–87]. Furthermore, we used the risk-of-bias table proposed by 
Cochrane [88] to check the presence of selection, performance, detection, attrition and reporting biases 
in the selected clinical trials. 
5. Conclusions 
This review attempted to shed light on the anti-caries activity of EOs and their isolated constituents. 
Certainly, EOs extracted from a variety of aromatic plants worldwide can be considered promising 
sources of bioactive molecules effective against caries-related microorganisms, particularly S. mutans; 
however, most of the knowledge in the literature is based on in vitro studies and on a limited number 
of clinical trials. Overall, the studies have assessed the effects of EO and isolated compounds on 
microbial growth rather than virulence factors (e.g., bacterial EPS synthesis), which play a key role in 
the aetiopathogenesis of dental caries. Attention is also drawn to the fact that a number of studies do 
not provide any chemical or botanical characterization data, raising concern about the reproducibility 
and accuracy of their findings. Scientific journals should be more stringent in the adoption of criteria 
for the publication of studies with natural products, particularly EOs. Due to the gap between the in vitro 
biological properties identified in EOs and their clinical use for the prevention of dental caries, future 
researches should focus on translational approaches to advance the development of effective anti-caries 
products containing EO, given that most of them are considered as GRAS by the FDA. 
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